Filing Details
- Accession Number:
- 0001209191-21-069098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-10 17:26:01
- Reporting Period:
- 2021-12-08
- Accepted Time:
- 2021-12-10 17:26:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1736315 | Peter Soparkar | C/O Adverum Biotechnologies, Inc. 800 Saginaw Drive Redwood City CA 94063 | See Remarks Section | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-08 | 25,000 | $1.91 | 258,631 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.895 to $1.92. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- Includes 1,015 shares and 1,923 shares purchased on November 20, 2020 and May 20, 2021, respectively, which were inadvertently not reflected as held on the Reporting Person's prior Forms 4, and 1 share purchased on November 22, 2021, in each case pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
Billionaire Hedge Funds
